Author Archives: John E. Fitzgibbon Jr.

May’s IPO market opened on Friday with a “blank check” company and a healthcare issue making their debuts. This week’s IPO Calendar has another two deals. One is a blank check and the other is a gaming company whose shares are being upgraded to the U.S. capital markets from the AIM market of the London […]

Four IPOs got priced last week while a small-cap Chinese deal was pushed onto this week’s calendar. China Liberal Education Holdings (CLEU proposed) is the carryover. (We’ll have more on this minute.) Last week had an interesting message. Since the U.S. stock market’s recent pullback, the calendar has been all about “blank check” IPOs and biotech […]

The coronavirus pandemic made itself felt in the 2020 securities markets and all but closed down the U.S. IPO market. There are no IPOs on the calendar this week, but things may have taken a positive turn over the last two weeks. On March 29th, The IPO Buzz headline read: Circle This. That was a […]

Just one IPO is in the wings this week – and it hails from the biopharma sector. This isn’t a coincidence. Any time an industrial sector outperforms the broad U.S. stock market, it can catch the investor’s eagle eye. This is what has happened since the three major U.S. stock indexes bottomed out on March […]